WORLDWIDE CLINICAL-DATA ON EFFICACY AND SAFETY OF CIPROFLOXACIN

被引:54
作者
SCHACHT, P
ARCIERI, G
BRANOLTE, J
BRUCK, H
CHYSKY, V
GRIFFITH, E
GRUENWALDT, G
HULLMANN, R
KONOPKA, CA
OBRIEN, B
RAHM, V
RYOKI, T
WESTWOOD, A
WEUTA, H
机构
[1] BAYER AG,PHARMA DEUTSCHLAND,D-5090 LEVERKUSEN,FED REP GER
[2] MILES PHARMACEUT,W HAVEN,CT 06516
[3] BAYER NEDERLAND BV,DIV FARMA,3644 RR MIJDRECHT,NETHERLANDS
[4] BAYER PHARMA SA,DEPT MED,F-92815 PUTEAUX,FRANCE
[5] BAYER SVERIGE AB,AVD KLIN PROVN,S-11145 STOCKHOLM,SWEDEN
[6] BAYER YAKUHIN LTD,OSAKA 54091,JAPAN
关键词
D O I
10.1007/BF01650504
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:S29 / S43
页数:15
相关论文
共 107 条
[1]   CLINICAL-EXPERIENCE WITH CIPROFLOXACIN IN THE USA [J].
ARCIERI, G ;
AUGUST, R ;
BECKER, N ;
DOYLE, C ;
GRIFFITH, E ;
GRUENWALDT, G ;
HEYD, A ;
OBRIEN, B .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1986, 5 (02) :220-225
[2]   MULTIPLE-DOSE CIPROFLOXACIN KINETICS IN NORMAL SUBJECTS [J].
ARONOFF, GE ;
KENNER, CH ;
SLOAN, RS ;
POTTRATZ, ST .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 36 (03) :384-388
[3]  
AZJNAR J, 1986, SEX TRANSM DIS, V13, P169
[5]   CIPROFLOXACIN - AN OVERVIEW OF ADVERSE EXPERIENCES [J].
BALL, P .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 :187-193
[6]   ANTIBACTERIAL ACTIVITIES OF CIPROFLOXACIN, NORFLOXACIN, OXOLINIC ACID, CINOXACIN, AND NALIDIXIC-ACID [J].
BARRY, AL ;
JONES, RN ;
THORNSBERRY, C ;
AYERS, LW ;
GERLACH, EH ;
SOMMERS, HM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (05) :633-637
[7]  
BASSARIS HP, 1986, 1ST INT CIPR WORKSH, P241
[8]   INVITRO ACTIVITY OF CIPROFLOXACIN, NORFLOXACIN AND NALIDIXIC-ACID [J].
BAUERNFEIND, A ;
PETERMULLER, C .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (02) :111-115
[9]  
BEERMANN D, 1986, 1ST INT CIPR WORKSH, P141
[10]  
BEERMANN D, 1986, CIPROFLOXACIN PRODUC, P42